12/27
08:08 am
tak
Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency [Yahoo! Finance]
Low
Report
Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency [Yahoo! Finance]
12/27
01:03 am
tak
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia [Yahoo! Finance]
Low
Report
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia [Yahoo! Finance]
12/27
01:00 am
tak
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
Low
Report
Takeda Announces Approval of HYQVIA® 10% S.C. (Subcutaneous) Injection Set in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
12/19
08:08 am
tak
Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative [Globe and Mail, The (Toronto, Canada)]
Low
Report
Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative [Globe and Mail, The (Toronto, Canada)]
12/12
05:30 pm
tak
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
Low
Report
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
12/11
07:14 pm
tak
Dietary Supplements Market in Japan is Expected to Reach USD 2,310.30 Million by 2033, Growing at a 6.2% CAGR | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Dietary Supplements Market in Japan is Expected to Reach USD 2,310.30 Million by 2033, Growing at a 6.2% CAGR | Future Market Insights, Inc. [Yahoo! Finance]
12/10
04:12 am
tak
Takeda Pharmaceutical (TSE:4502) Advances with New Product Update and Strategic Alliances for Growth [Yahoo! Finance]
Low
Report
Takeda Pharmaceutical (TSE:4502) Advances with New Product Update and Strategic Alliances for Growth [Yahoo! Finance]
12/3
07:00 am
tak
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
Low
Report
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics
11/30
04:38 pm
tak
Why Takeda (TAK) Is One of the Most Profitable Pharmaceutical Stocks Right Now? [Yahoo! Finance]
Low
Report
Why Takeda (TAK) Is One of the Most Profitable Pharmaceutical Stocks Right Now? [Yahoo! Finance]
11/29
08:39 am
tak
Takeda Canada co-sponsors grant to boost IBD clinical research [Yahoo! Finance]
Low
Report
Takeda Canada co-sponsors grant to boost IBD clinical research [Yahoo! Finance]
11/28
09:12 am
tak
Dr. Kevan Jacobson and Dr. Genelle Lunken Awarded $1M Pioneer Grant for Transformative Pediatric Research in Inflammatory Bowel Disease [Globe and Mail, The (Toronto, Canada)]
Low
Report
Dr. Kevan Jacobson and Dr. Genelle Lunken Awarded $1M Pioneer Grant for Transformative Pediatric Research in Inflammatory Bowel Disease [Globe and Mail, The (Toronto, Canada)]
11/28
07:09 am
tak
$115+ Billion Blood Plasma Derivatives Global Market Trends, Opportunities and Strategies to 2033: Innovative Formulations, Strategic Partnerships, and Increasing Investments to Drive Developments [Yahoo! Finance]
Low
Report
$115+ Billion Blood Plasma Derivatives Global Market Trends, Opportunities and Strategies to 2033: Innovative Formulations, Strategic Partnerships, and Increasing Investments to Drive Developments [Yahoo! Finance]
11/20
11:41 am
tak
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform [Yahoo! Finance]
Low
Report
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform [Yahoo! Finance]
11/20
11:30 am
tak
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform
Low
Report
Alloy Therapeutics Signs Collaboration and License Agreement with Takeda to Develop Cell Therapy Platform
11/19
07:49 am
tak
Latigo Biotherapeutics Appoints Industry Veteran Timothy P. Walbert as Board Chair [Yahoo! Finance]
Neutral
Report
Latigo Biotherapeutics Appoints Industry Veteran Timothy P. Walbert as Board Chair [Yahoo! Finance]
11/4
08:14 am
tak
New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD [Yahoo! Finance]
Low
Report
New Survey Data Highlights the Importance of Prioritizing Mental Health for Canadians Living with IBD [Yahoo! Finance]
10/31
02:06 am
tak
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook [Yahoo! Finance]
Low
Report
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook [Yahoo! Finance]
10/31
02:05 am
tak
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
Low
Report
Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
10/24
08:00 am
tak
Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
Low
Report
Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
10/10
04:17 pm
tak
GZERO Summit Japan convenes top political and business leaders to address current geopolitical challenges and opportunities [Yahoo! Finance]
Low
Report
GZERO Summit Japan convenes top political and business leaders to address current geopolitical challenges and opportunities [Yahoo! Finance]
10/10
04:00 pm
tak
GZERO Summit Japan convenes top political and business leaders to address current geopolitical challenges and opportunities
Low
Report
GZERO Summit Japan convenes top political and business leaders to address current geopolitical challenges and opportunities
10/8
10:00 pm
tak
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking
Low
Report
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking